About
Technology
Issues
FAQ
Links
Official Page
Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.